Natural Capsules Q2 FY27 Results: Revenue Up 5%, PAT ₹3.01 Cr

Natural Capsules Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, the company reported a 5% increase in revenue and a Profit After Tax (PAT) of ₹3.01 crore. The Executive Director highlighted a strategic conversion of HPMC lines to gelatine lines, which drove growth due to increased gelatine volumes. Realization improvements from the previous quarter were maintained. The company also reported progress in its API business with a new CEO appointment and a focus on market registrations. Challenges in logistics and rising raw material costs are anticipated, with plans to pass on increases to customers. New customers, including Mankind Pharma, were added, and an audit by Zydus Lifesciences was successfully completed.